Skip to content

Comparison between needle injection and needle less jet injection in patients with pain in upper teeth undergoing root canal treatment

“Comparative Evaluation of clinical efficacy of local anesthesia delivered using conventional injections vs needle less Jet injector in maxillary teeth with symptomatic irreversible pulpitis- A Randomized Clinical Study. ?

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045420
Enrollment
60
Registered
2022-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Needle less jet injection: frequency- the injection will be given before the endodontic treatment and will be evaluated immediately. No follow up needed Control Intervention1: Conventio

Sponsors

Aishwarya Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systemically healthy patients (Category: American Society of Anesthesiologists class 2 or less than 2)(15) between 18 – 60 years of age with maxillary teeth diagnosed with symptomatic irreversible pulpitis having lingering pain which is continuous in nature will be included in the study. 2. Tooth with moderate to deep caries, which shows VAS scale more than 3, will be included in the study. 3. A written informed consent will be taken from all the patients and only those patients ready to sign the consent form will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to lignocaine will be excluded from the study 2. Non-vital teeth /acute apical abscess / phoenix abscess that will give negative response to EPT will be excluded from the study. 3. Patients who had taken analgesic medication 12 hrs before the treatment will be excluded from the study 4. Patients with fractured or visibly cracked tooth, developmental anomalies, pathology or open apex will be excluded from the study 5. Pregnant and lactating women will be excluded. 6. Medically compromised patients and patients with history to any substance abuse will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Efficacy of injection will be assessed using VAS (0 to 10 point) scale.Timepoint: Efficacy of injection will be assessed after 10 mins of injection

Secondary

MeasureTime frame
The onset of LA will be evaluated at 1 min, 3 mins and 5 mins using pulp sensibility tests.Timepoint: Evaluation will be done after 1 min, 3 mins, 5 mins of injection;The pain on injection will be evaluated using VAS pain scale (0-10 point scale)Timepoint: The pain on injection will be assessed immediately

Countries

India

Contacts

Public ContactAishwarya jain

KM Shah Denatl college and hospital

nshah7873@gmail.com9998994299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026